康泰医学2025年预亏收窄，资金面波动引关注

Core Viewpoint - Kangtai Medical (300869) has announced a projected net profit loss of between 17 million to 33 million yuan for 2025, indicating a reduction in losses compared to the previous year [1][2]. Group 1: Financial Performance - The company expects a net profit loss of 17 million to 33 million yuan for the fiscal year 2025, which is an improvement from the loss of 77.9 million yuan in the same period last year, primarily due to a decrease in inventory impairment provisions [2]. Group 2: Convertible Bonds - The issuance of Kangyi Convertible Bonds (bond code: 123151) has been terminated, with the conversion period extending until June 30, 2028. A small amount of conversion is expected to be completed in the fourth quarter of 2025, which may impact the company's capital structure [3]. Group 3: Stock Price and Fund Flow - In January 2026, the company's main fund flow exhibited volatility, with a net inflow of 3.146 million yuan on January 9, followed by a cumulative decline of 6.14% in stock price by January 30. These fluctuations may reflect short-term market sentiment changes [4].